Wei Dong Wang

Fortuna: 43 M $ al 31/03/2024

65 años

Health Technology

Consumer Services

Perfil

Fundador de RemeGen Co., Ltd. y de Yantai Rongchang Pharmaceutical Co. Ltd., Weidong Wang ocupa actualmente el cargo de presidente de Yantai Rongchang Pharmaceutical Co. Ltd. y presidente de RemeGen Co. Se licenció en la Universidad de Comercio de Harbin.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
REMEGEN CO. LTD. CLASS A 2.57%	28/12/2022	4 111 338 ( 2.57% )	31 M $	31/03/2024
REMEGEN CO. LTD. CLASS H 1.89%	01/10/2023	3 584 541 ( 1.89% )	12 M $	31/03/2024

Cargos activos de Wei Dong Wang

Empresas	Cargo	Inicio
REMEGEN CO., LTD.	Founder	04/07/2008
Yantai Rongchang Pharmaceutical Co. Ltd.	Founder	01/03/1993
MabPlex International Co., Ltd. MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China.	Director/Board Member	25/06/2013

Todos los cargos activos de Wei Dong Wang

Formación de Wei Dong Wang.

Harbin University of Commerce

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Wei Dong Wang.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
REMEGEN CO., LTD.	Health Technology

Empresas privadas	2
MabPlex International Co., Ltd. MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China.	Health Technology
Yantai Rongchang Pharmaceutical Co. Ltd.